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Parathyroid hormone-related protein is produced by
many normal tissues including the skin, where it
regulates growth and differentiation of keratinocytes.
To define better the role of parathyroid hormone-
related protein in the skin, we investigated the spatial
and temporal expression of parathyroid hormone-
related protein and mRNA by immunohistochemistry
and in situ hybridization during the healing of skin
wounds, and the effects of topical administration
of a parathyroid hormone-related protein agonist
[parathyroid hormone-related protein (1–36)] and a
parathyroid hormone-related protein antagonist [para-
thyroid hormone (7–34)] on the healing rate and
morphology of the wounds. Wounds were produced
on the back of guinea pigs with a 4 mm punch, and
wound sites were collected at different time points
during the healing process. Parathyroid hormone-
related protein was expressed in normal skin by all
viable keratinocyte layers, hair follicles, and adnexae.
Following injury, migratory keratinocytes at wound
margins and the newly restored epidermis expressed
increased levels of parathyroid hormone-related pro-
tein. The remodeling phase was associated with pro-
gressive restoration of the pattern of parathyroid
hormone-related protein expression in normal epi-
Parathyroid hormone-related protein (PTHrP) was ini-tially purified from human tumors associated with thesyndrome of humoral hypercalcemia of malignancyand plays a central part in the pathogenesis of thisparaneoplastic syndrome in human beings and animals
(Rosol and Capen, 1992; Gro¨ne et al, 1994). Subsequently, PTHrP
has been shown to be produced by many normal tissues, where it
acts as a paracrine or autocrine cytokine with many potential
functions, including regulation of cell growth and differentiation,
regulation of smooth muscle cell relaxation and transepithelial
calcium transport (Philbrick et al, 1996).
PTHrP is expressed at high levels by keratinocytes, where its
major function is suggested to be the regulation of cell growth and
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dermis. Granulation tissue myofibroblasts and infilt-
rating macrophages also expressed parathyroid
hormone-related protein. In vitro studies using THP-1
cells (a promonocytic cell line) confirmed that macro-
phages expressed parathyroid hormone-related
protein, especially after activation. Topical application
of parathyroid hormone related protein (1–36) or
parathyroid hormone (7–34) did not result in significant
changes in the healing rate and morphology of the
wounds. These findings demonstrated that, in addition
to keratinocytes, myofibroblasts and macrophages also
represent sources of parathyroid hormone-related pro-
tein during the healing of skin wounds. Although the
data suggest a role for parathyroid hormone-related
protein in the healing of skin and in the restoration of
epidermal homeostasis, parathyroid hormone-related
protein does not appear to be required for proper
re-epithelialization in response to injury, potentially
because of redundancy in epidermal growth and
wound healing, as has been shown for other paracrine
and autocrine growth factors of the epidermis. Key-
words: contraction/differentiation/keratinocyte/myofibro-
blast/parathyroid hormone-related protein. J Invest Dermatol
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differentiation (Werkmeister et al, 1993, 1998; Kaiser et al, 1994).
PTHrP has been reported to inhibit keratinocyte proliferation
in vitro (Holick et al, 1994; Kaiser et al, 1994). In addition, hairless
mice injected with PTHrP antagonists exhibited hair growth with
increased keratinocyte proliferation (Holick et al, 1994). A major
role of PTHrP in the maintenance of epidermal homeostasis was
demonstrated by several in vivo studies using transgenic mice.
Transgenic mice overexpressing PTHrP in their basal keratinocytes
had defects in hair follicle development, whereas PTHrP
‘‘knockout’’ mice developed surface hyperkeratosis and sebaceous
gland hypoplasia (Wysolmerski et al, 1994; Philbrick et al, 1996).
PTHrP acts on keratinocytes by binding to and activating an
uncharacterized receptor, which uses calcium ion as a second
messenger (Orloff et al, 1992).
PTHrP produced by keratinocytes also may interact with and
regulate the function of dermal fibroblasts. Dermal fibroblasts
express the classic type 1 PTH/PTHrP receptor, but usually do
not express PTHrP (Hanafin et al, 1995; Philbrick et al, 1996). It
has been suggested that PTHrP is one of the cytokines involved
in dermal–epidermal cooperativity (Philbrick et al, 1996). This is
VOL. 112, NO. 5 MAY 1999 PTHrP IN WOUND HEALING 789
supported by the findings of abnormal dermal features in both
PTHrP ‘‘knockout’’ mice and PTHrP-overexpressing transgenic
mice (Wysolmerski et al, 1994; Philbrick et al, 1996).
Growth factors and cytokines play an important role in the
regulation of tissue repair and regeneration. In the skin, wound
healing is a dynamic, complex, and highly regulated process
associated with the release of cytokines and growth factors present
in the serum or produced and secreted by resident cells of the skin
and infiltrating leukocytes (McKay and Leigh, 1991; Feiken et al,
1995). Keratinocytes and fibroblasts undergo marked phenotypic
alterations during the healing of skin wounds. The specific signals
triggering these alterations are not completely understood, but it is
likely that cytokines and growth factors, as well as changes in the
nature of the extracellular matrix, play a crucial part (McKay and
Leigh, 1991; Saarialho-Kere et al, 1993; Inoue et al, 1995).
In this study, we investigated the spatial and temporal expression
of PTHrP by immunohistochemistry and in situ hybridization in
wounds artificially created on the back of guinea pigs in an attempt
to better define the biologic functions of PTHrP, as well as the
factors influencing its expression. In addition, we investigated the
effects of topical administration of a PTHrP agonist and a PTHrP
antagonist on the healing rate and morphology of the wounds.
MATERIALS AND METHODS
Animals Ten male and four female Duncan–Hartley guinea pigs, weighing
450–500 g, were obtained from Harlan Sprague–Dawley (Indianapolis, IN).
The guinea pigs were housed two per cage under constant humidity and
temperature, with 12 h light/12 h dark cycles. They were allowed ad
libitum access to water and standard guinea pig feed, were monitored daily
and were weighed weekly. All experimental procedures received approval
by the Institutional Laboratory Animal Care and Use Committee of The
Ohio State University.
Excisional wounds, biopsy sampling and treatment with PTHrP
agonist and antagonist Guinea pigs were anesthetized by subcutaneous
injection of ketamine (40 mg per kg) and xylazine (5 mg per kg). Under
anesthesia, the hair of their back was clipped, the skin was cleaned and
disinfected with povidone-iodine solution (Prepodyne, West Agro, Kansas
City, MO), and six excisional wounds were made on the back of each
animal (three on the right side and three on the left side) using a 4 mm
punch. To evaluate PTHrP expression during wound healing, biopsies of
the wounds were aseptically removed under anesthesia at 12 time points
(1, 2, 3, 4, 5, 6, 8, 10, 13, 16, 21, and 28 d post-wounding) by elliptical
incisions using a sterile scalpel blade. Two males and two females were
used at each time point and only one wound site was removed per animal
at each time point. The biopsy site was aseptically closed by a subcuticular
suture (Dexon, 3-0).
To evaluate the role of PTHrP in the healing process, 1 µg PTHrP(1–
36) (generously provided by Procter and Gamble, Cincinnati, OH) and
1 µg bovine (Nle8,18, Tyr34)-PTH(7–34) amide (Bachem, Torrance, CA)
were topically applied to the wound surfaces of six guinea pigs every 24 h
until being killed. PTHrP(1–36) and PTH(7–34) were resuspended in
phosphate-buffered saline (PBS) or in a mixture of 30% PBS/70% propylene
glycol at a concentration of 100 ng per µl and 10 µl were applied to the
wound surfaces. Two vehicles [hydrophilic (PBS) and lipophilic (PBS/
propylene glycol)] were tested in parallel (three guinea pigs per vehicle),
as re-epithelialization and crusting were expected to affect transepidermal
transport. Each guinea pig had two wounds treated with the vehicle (PBS
or PBS/propylene glycol), two wounds treated with PTHrP(1–36), and
two wounds treated with PTH(7–34). Animals were monitored daily and
the macroscopic appearance and size of the wounds recorded. Guinea pigs
were killed 6, 12, and 18 d after wound induction and the wound sites
collected at killing.
Morphologic and immunohistochemical analysis Biopsy samples
were fixed in 10% buffered formalin, routinely processed, and embedded
in paraffin. Paraffin sections (5 µm) were used for histology, immunohisto-
chemistry, and in situ hybridization.
For immunohistochemistry and lectin histochemistry, sections were
dewaxed in xylene, rehydrated in decreasing concentrations of ethanol,
and endogenous peroxidase was blocked with 1.5% hydrogen peroxide for
15 min. All primary antibodies and lectin were diluted in PBS. Primary
antibodies were for vimentin (Biogenex, San Ramon, CA; working dilution
1:400), desmin (Biogenex; working dilution 1:25), lysozyme (Dako,
Carpenteria, CA; working dilution 1:150), α-smooth muscle actin
(Boehringer Mannheim, Indianapolis, IN; working dilution 1:100) and
midregion PTHrP(34–53) (Oncogene Research, Cambridge, MA; working
dilution 1:100). Biotinylated Griffonia (Bandeiraea) simplicifolia Lectin I (GSL
I; Vector, Burlingame, CA; working dilution 1:25) was used to identify
endothelial cells. Universal Secondary Antibody (Research Genetics,
Huntsville, AL) was used for vimentin, desmin, and α-smooth muscle
actin detection, whereas biotin-labeled goat anti-rabbit IgG antibody
(Zymed, San Francisco, CA) was used for detection of PTHrP and
lysozyme. Slides were incubated with avidin–biotin–horseradish-peroxidase
complex (ImmunoPure Ultra-Sensitive ABC Staining Kit, Pierce, Rock-
ford, IL), and peroxidase activity was detected by incubating the sections
for up to 4 min in Stable DAB (Research Genetics). Primary anti-PTHrP
antibodies were preincubated with PTHrP(34–53) (500 µg per ml) before
use as a negative control to demonstrate specificity of the immunohisto-
chemical staining.
Preparation of riboprobe A PTHrP riboprobe to the common coding
exon VI was obtained by subcloning a 422 bp genomic PCR fragment,
corresponding to the region 1102 to 1524 of the human PTHrP gene
(Suva et al, 1987), into the EcoRI site of pAM-19 (Amersham International,
Bucks., U.K.) in both orientations. The plasmid was linearized with BamHI
and transcribed with either T7 or Sp6 RNA polymerase to yield anti-
sense and sense riboprobes, respectively. The riboprobes were labeled with
digoxigenin (DIG) during RNA transcription using an RNA labeling kit
(Boehringer).
In situ hybridization In situ hybridization for PTHrP mRNA was
performed as previously described with minor modifications (Zhou et al,
1994; Kartsogiannis et al, 1997). Sections were dewaxed with xylene and
rehydrated with decreasing concentrations of ethanol before rinsing in
diethylpyrocarbonate-treated water (DEPC-H2O). Deproteinization was
carried out with 0.2 M HCl for 20 min at room temperature followed by
digestion with proteinase K at 5–10 µg per ml in 0.1 M Tris buffer
(pH 8.0)/50 mM EDTA for 30 min at 37°C. Proteinase K was inactivated
by the addition of 2 mg per ml glycine in PBS for 5 min. Tissue sections
were postfixed in 4% paraformaldehyde in PBS for 15 min at room
temperature. Prehybridization was performed at 37°C for 1 h in hybridiza-
tion buffer [50% formamide, 5 3 sodium citrate/chloride buffer (SSC),
2% blocking reagent (Boehringer Mannheim), 0.1% N-lauroyl-sarcosine,
and 0.02% sodium dodecyl sulfate]. Hybridization was performed at 42°C
for 16–18 h in a humidified chamber with hybridization buffer containing
the DIG-labeled probe at a final concentration of 1–4 ng per µl. After
hybridization, slides were washed in 2 3 SSC at 37°C for 15 min, treated
with 25 µg per ml RNase A (Sigma, St Louis, MO) in 2 3 SSC for
30 min at 37°C to remove nonhybridized RNA, and successively washed
once in 2 3 SSC, twice in 1 3 SSC, and twice in 0.1 3 SSC at 37°C
for 15 min each. The hybridized probe was detected using alkaline
phosphatase-coupled anti-DIG antibody (Boehringer Mannheim) after
blocking for nonspecific binding with a combination of 30% rabbit serum,
3% bovine serum albumin (Sigma), and 0.1% Triton X-100 (Sigma) in
PBS for 30 min. Alkaline phosphatase activity was detected with BCIP/
NBT solution substrate (Boehringer Mannheim) and sections were coun-
terstained with nuclear fast red. Negative controls consisted of sections
hybridized with a sense riboprobe or treated for 2 h at 37°C with 100 µg
per ml RNase A (Sigma) in 2 3 SSC prior to prehybridization.
Cell culture THP-1 (a promonocytic cell line) cells were grown in
RPMI medium (Sigma) supplemented with glutamine (Gibco-BRL) and
10% fetal bovine serum. These cells were inactive under these conditions,
but could easily be activated by treatment with phorbol esters or interleukin-
1α (IL-1; kindly donated from Hoffmann-La Roche, Nutley, NJ). In order
to evaluate PTHrP secretion and mRNA expression by unactivated and
activated THP-1 cells, cells were grown in 12 well and 90 mm plates and
treated with vehicle (PBS), PMA (phorbol 12-myristate 13-acetate, 50 µM),
or IL-1 (100 ng per ml). RNA was collected after 6 h of treatment, and
conditioned medium and cell extracts were collected 24 h after treatment.
To collect cell extracts, cells were resuspended in PBS and lysed by three
freeze–thaw cycles.
PTHrP nonequilibrium radioimmunoassay (RIA) and DNA
quantitation The RIA for PTHrP was performed as described by our
laboratory using chicken polyclonal anti-PTHrP(1–36) antibody (Rosol
et al, 1993). [Tyr36]-PTHrP(1–36) (Bachem) was radioiodinated with 125I
and Iodogen (Pierce) and purified using reverse-phase HPLC. Polyclonal
chicken anti-PTHrP(1–36) antibodies (10 mg per ml in PBS, 1:1000
dilution) were added to borosilicate tubes containing standards or medium
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samples (100 µl) and assay buffer (20 mM sodium phosphate, pH 7.4,
140 mM NaCl, 50 mM EDTA, 0.5% BSA, 0.1 sodium azide) and were
incubated for 48 h at 4°C. Iodinated PTHrP(1–36) was added (10 000 cpm
per tube) and dextran-coated charcoal (5 mg per ml activated charcoal,
0.5 mg per ml dextran) was utilized to separate the bound from free
PTHrP after 48 h. The supernatant was measured in a gamma-radiation
counter and PTHrP content quantitated by log-logit transformation using
Securia 1.0 (Packard Instruments, Downers Grove, IL). The RIA was
sensitive to 0.1 ng PTHrP(1–36) per ml of medium. PTHrP concentrations
in conditioned medium were standardized for total DNA present in each
well. DNA content of cell extracts was determined by DNA fluorimetry.
Calf thymus DNA was used to generate a standard curve. Hoechst 33258
dye (Hoefer Scientific Instruments, San Francisco, CA; 2 µg per ml in
TNE buffer (10 mM Tris, 1 mM EDTA, 100 mM NaCl, pH 7.4); 100 µl
per well) was added to black U-bottom microfluor plate wells (Dynatech
Laboratories, Webster, NY) containing standards or cell extracts diluted in
TNE buffer (100 µl per well). After 5 min of incubation, the fluorescence
was determined using a fluorescence concentration analyzer (Idexx Laborat-
ories, Westbrook, ME) with the signal channel set to 365/450 nm with
the gain set at 5. DNA content was quantitated by linear transformation.
Reverse transcription and polymerase chain reactions Oligo-
nucleotide primers for the PTHrP gene were designed for reverse tran-
scriptase-polymerase chain reaction (PCR) based on published sequences
and amplified a 321 bp fragment (Yasuda et al, 1989). The sequence of the
sense primer was 59-CAGTGGAGCGTCGCGGTGTTC-39, a region in
exon 3 of the human PTHrP gene, and the sequence of the anti-sense
primer was 59-GTACGTCTCCACCTTG-39, a region in exon 4 of the
human PTHrP gene. Primers for glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) were based on published human sequences and have
been previously shown to amplify a 229 bp fragment of the canine GAPDH
gene (Gro¨ne et al 1996). The sequence of the sense primer was 59-
GCCAAAAGGGTCATCATCTC-39, a region in exon 6 of the human
GAPDH gene, and the sequence of the anti-sense primer was 59-
GGCCATCCACAGTCTTCT-39, a region in exon 8 of the human
GAPDH gene. Oligonucleotides were synthesized by Integrated DNA
Technologies (Coralville, IA).
Total RNA was isolated with TRIzol (Gibco-BRL). cDNAs were
synthesized from 1 µg of total RNA with M-MLV reverse transcriptase
(Gibco-BRL). Half of the cDNA from each sample was used for the PCR
amplification of the PTHrP cDNA, and the other half was used for PCR
amplification of GAPDH cDNA. The PCR reaction was run for a total
of 40 cycles at the following temperatures and times: 94°C (20 s), 55°C
(20 s), and 72°C (1 min).
RESULTS
Histologic and immunohistochemical characterization of
the healing process and effect of PTHrP(1–36) and PTH(7–
34) The epidermis of the dorsum of normal guinea pigs was four
to five cells thick with basal, spinous, granular, and cornified layers.
The dermis and hypodermis were similar to other species. The
healing process could be divided into three successive phases: an
inflammatory phase from days 1 to 7, a granulation tissue phase
from days 8 to 14, and a remodeling phase from days 15 to
28 (Fig 1). Epithelial migration continued until complete re-
epithelialization was achieved at approximately day 7. Fibroblasts
and neocapillaries of the granulation tissue expressed high levels of
α-smooth muscle actin, whereas fibroblasts from the normal dermis
did not demonstrate immunoreactivity (Fig 2). Fibroblasts were
negative for desmin, whereas spindle-shaped cells (pericytes) sur-
rounding neocapillaries in the granulation tissue and capillaries of
normal dermis were positive for desmin. Endothelial cells of
granulation tissue capillaries were intensely stained by GSL-I
histochemistry (Fig 3). Following daily topical application of
PTHrP(1–36) or PTH(7–34), no differences in the healing rate,
macroscopic appearance, and histology of the wounds were
detected (Fig 4).
PTHrP expression in normal guinea pig skin In normal
guinea pig skin, PTHrP protein and mRNA were demonstrated
in all the viable layers of the epidermis (Fig 5). Intense immuno-
histochemical staining was present in the thin granular cell layer.
The staining in this layer was partially nonspecific, as the staining
was not completely eliminated after preincubation of the primary
Figure 1. Histology of the three phases of the healing process. (a)
Edge of a wound at day 1. Arrowhead points to the flap of keratinocytes
migrating toward the center of the wound (on the left side of the
photograph). Note the band of degenerate leukocytes and cellular debris
underneath the fibrin clot. (b) Wound at day 10. Wounds were completely
re-epithelialized and contained dense granulation tissue, but the newly
formed epidermis was only weakly attached to the underlying basement
membrane, as shown by the epidermal–dermal separation (arrowhead)
induced during biopsy sampling. (c) Wound at day 28. There was still
evidence of granulation tissue in the dermis (arrowhead) and mild epidermal
hyperplasia with orthokeratotic hyperkeratosis. Scale bar: 400 µm (a), 1 mm
(b, c).
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Figure 2. a-Smooth muscle actin immunohistochemistry of
granulation tissue fibroblasts. Note the intense immunoreactivity of
most fibroblasts. Scale bar: 100 µm.
Figure 3. Griffonia simplicifolia Lectin I histochemistry of
granulation tissue endothelial cells. Note the intense brown staining
of endothelial cells forming neocapillaries (arrows). Scale bar: 50 µm.
antibody with synthetic peptide [PTHrP(34–53)] and increased
PTHrP mRNA compared with other layers of the epidermis was
not detected by in situ hybridization. In addition, PTHrP protein
and mRNA were demonstrated in hair follicle keratinocytes,
sebaceous and apocrine glands, arrector pili muscles, endothelial
cells of capillaries, and fibers of the panniculus carnosus skeletal
muscle. Approximately 30% of dermal interstitial cells interpreted
as dermal fibroblasts also were positive for PTHrP by immunohisto-
chemistry and in situ hybridization.
PTHrP expression is upregulated in keratinocytes involved
in re-epithelialization During the inflammatory phase of the
healing process, flaps of migrating keratinocytes demonstrated
intense, full-thickness immunoreactivity for PTHrP (Fig 6a). With
in situ hybridization, migrating keratinocytes were more intensely
stained than the keratinocytes from adjacent normal skin (Fig 6b).
In wounds biopsied during the granulation tissue phase, the newly
formed intact epidermis was stained more intensely for PTHrP
protein and mRNA in comparison with the epidermis from the
adjacent normal skin (Fig 7). During the remodeling phase, the
restored epidermis showed a pattern and level of PTHrP expression
comparable with normal epidermis.
Myofibroblasts and neocapillaries of the granulation tissue
express PTHrP protein and mRNA Proliferating spindle cells
Figure 4. Histology of the wounds at day 12 after treatment. (a)
Vehicle control. (b) PTHrP(1–36). (c) PTH(7–34). When compared with
wounds treated with the vehicle, wounds treated daily by topical application
of either PTHrP(1–36) or PTH(7–34) did not differ histologically. Scale
bar: 1 mm.
of the immature granulation tissue were moderately positive for
PTHrP protein. During the granulation tissue phase, intense
immunoreactivity for PTHrP was present in granulation tissue cells
(Fig 7a). The decreased cellularity of the dermis associated with
the remodeling phase was associated with decreased staining of
granulation tissue cells for PTHrP protein. In situ hybridization,
confirmed that myofibroblasts and neocapillaries of the early and
mature granulation tissues expressed PTHrP mRNA, although the
intensity of staining was weak to moderate (Fig 7b). During the
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Figure 5. PTHrP expression in normal guinea pig skin. (a)
Immunohistochemistry. (b) In situ hybridization. (c) Negative control for
in situ hybridization. The epidermis (e), hair follicles (f), sebaceous glands
(s), and arrector pili muscles (a) were stained positive with both techniques.
Arrowhead points to the nonspecific immunohistochemical staining of the
granular layer. Scale bar: 10 µm.
remodeling phase, there was a progressive decrease in staining for
PTHrP mRNA in these cells.
Macrophages infiltrating early wounds and grown in vitro
express PTHrP protein and mRNA Leukocytes infiltrating
early wounds and covering the early granulation tissue contained
frequent cells demonstrating weak to moderate staining by immuno-
Figure 6. PTHrP expression by keratinocytes involved in re-
epithelialization. Immunohistochemistry (a) and in situ hybridization (b)
of wound edges at day 4. Flaps of migrating keratinocytes demonstrated
intense immunoreactivity for PTHrP and increased levels of PTHrP
mRNA in comparison with adjacent normal skin. Myofibroblasts of the
early granulation tissue also were mildly positive with both techniques
(arrowheads). Scale bar: 200 µm.
histochemistry and in situ hybridization for PTHrP (Fig 8). These
cells were interpreted to be macrophages based on their histologic
appearance and expression of lysozyme (Fig 8c).
To confirm PTHrP expression by monocytes/macrophages and
to evaluate whether the state of activation influences the level of
PTHrP expression, unactivated and activated THP-1 cells were
evaluated for PTHrP secretion and mRNA expression. While the
level of PTHrP in the conditioned medium of unactivated THP-1
cells was below the level of detectability, THP-1 cells activated by
either PMA or IL-1 secreted increased levels of PTHrP (Fig 9).
Similarly, PTHrP mRNA was detected by reverse transcriptase-
PCR in activated THP-1 cells, confirming the in vitro secretion
data. The reverse transcriptase-PCR results suggested that PTHrP
mRNA levels were low in unactivated cells when compared with
GAPDH and that PTHrP mRNA was increased in THP-1 cells
activated by PMA and IL-1 (Fig 10).
DISCUSSION
PTHrP plays a major role in the maintenance of epidermal
homeostasis, as shown by several in vivo studies using transgenic
mice or PTHrP antagonists (Holick et al, 1994; Wysolmerski et al,
1994; Philbrick et al, 1996). In the skin, PTHrP is produced by
keratinocytes and is involved in the regulation of keratinocyte
growth and differentiation. In this study, we confirmed abundant
PTHrP expression by keratinocytes of different phenotypes, but
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also demonstrated the novel finding of PTHrP protein and mRNA
expression by infiltrating leukocytes and granulation tissue myo-
fibroblasts.
Keratinocytes involved in the process of re-epithelialization
undergo marked phenotypic changes and secrete multiple enzymes
and growth factors. These keratinocytes migrate extensively and
proliferate at a high rate (McKay and Leigh, 1991; Cavani et al,
1993; Saarialho-Kere et al, 1993). Multiple factors contribute to
these changes, including cytokines and growth factors present
in the surrounding environment and changes in the supporting
extracellular matrix (McKay and Leigh, 1991; Saarialho-Kere et al,
1993; Feiken et al, 1995). During re-epithelialization, migrating
keratinocytes temporarily lose contact with the basement membrane
and are in direct contact with collagen. This change in supporting
extracellular matrix modulates keratinocyte phenotype, including
PTHrP expression (Blomme et al, 1998a; Saarialho-Kere et al,
1993; Inoue et al, 1995).
In this study, basal keratinocytes bordering the sites of active re-
epithelialization expressed high levels of PTHrP. It is likely that
PTHrP production by these migrating keratinocytes was modulated
by cytokines, growth factors, and extracellular macromolecules
present in their microenvironment. For example, factors present in
early wounds have been reported to stimulate PTHrP production
Figure 7. PTHrP expression during the granulation tissue phase.
Immunohistochemistry (a) and in situ hybridization (b) of wounds at day
13. The newly formed epidermis stained intensely for PTHrP protein and
mRNA. The intensity of staining was more intense than in the adjacent
normal skin. Myofibroblasts (arrowheads) also were mildly positive with
in situ hybridization, and the intensity of staining was comparable with
that of endothelial cells (arrow), a cell known to produce PTHrP. Scale bar,
400 µm (a), 100 µm (b).
by keratinocytes in vitro, including transforming growth factor-β
and epidermal growth factor (Merryman et al, 1993; Werkmeister
et al, 1998). We have shown that in vitro growth of basal keratinocytes
on type I collagen was associated with decreased PTHrP production
and secretion compared with growth on basement membrane
proteins (Matrigel) (Blomme et al, 1998a).
PTHrP inhibited proliferation and stimulated differentiation of
keratinocytes in vitro and in vivo (Holick et al, 1994; Kaiser et al,
1994). Because of these biologic properties, PTHrP has been
suggested as a potential treatment for psoriasis (Holick et al, 1996),
a condition where keratinocytes have a phenotype similar to
wound-edge keratinocytes (Kellner et al, 1991). Therefore, evidence
supports a role for PTHrP in the regulation of keratinocyte
growth and differentiation in skin wounds in which PTHrP would
antagonize the proliferative effects of cytokines and growth factors
released in early wounds (McKay and Leigh, 1991; Werner et al,
1992). This role would not be inconsistent with the biologic actions
of PTHrP, as a similar role has been reported for PTHrP in
developing bones in which PTHrP modulates the rate of chondro-
cyte differentiation permitting proper morphogenesis of the skeleton
(Vortkamp et al, 1996).
A ‘‘chalone’’ model for PTHrP in the epidermis has been
proposed, suggesting that PTHrP produced by differentiated epi-
dermal cells inhibits proliferation and promotes differentiation of
basal keratinocytes (Philbrick et al, 1996). During the late phases of
the healing process, the hyperplastic epidermis produced abundant
PTHrP. Increased production might contribute to the progressive
restoration of epidermal homeostasis. PTHrP produced by keratino-
cytes may also interact with and regulate the function of dermal
fibroblasts. PTHrP stimulated human dermal fibroblast proliferation
and fibronectin production in vitro (Insogna et al, 1989). In addition,
transgenic mice overexpressing PTHrP in basal keratinocytes have
an expanded hypercellular dermis (Wysolmerski et al, 1994). In our
study, increased cellularity of the injured dermis correlated with
increased PTHrP expression by keratinocytes in the wound, and
remodeling of the granulation tissue was associated with decreased
PTHrP production by keratinocytes. This temporal pattern of
expression indicates a potential role for PTHrP in the formation
of granulation tissue, where PTHrP would stimulate proliferation
of granulation tissue fibroblasts and their production of extracellular
matrix components, such as fibronectin.
PTHrP expression by fibroblasts in granulation tissue was un-
expected, as dermal fibroblasts are among the few cells reported
not to produce PTHrP (Philbrick et al, 1996). The granulation
tissue fibroblasts had a phenotype different from normal dermal
fibroblasts. They expressed α-smooth muscle actin and were
consistent with myofibroblasts (Darby et al, 1990). Myofibroblasts
are thought to be responsible for wound contraction. Many aspects
of myofibroblast biology are still unclear, such as the factors
regulating the expression of α-smooth muscle actin in these cells
(Rubbia-Brandt et al, 1991; Desmouliere et al, 1992, 1993). We
have previously observed a similar association between PTHrP and
α-smooth muscle actin expression in dermal fibroblasts cultivated
in collagen gels in vitro and in prostate stromal cells (Blomme et al,
1998b, c). The function of PTHrP in these cells is unknown, but
based on the effect of PTHrP on smooth muscle cells of the
reproductive or gastrointestinal tract (Philbrick et al, 1996), we
suggest that PTHrP may be involved in the regulation of contraction
of these cells. Therefore, PTHrP could have potential therapeutic
applications in the clinical management of fibrocontractive diseases
such as scleroderma (Skalli et al, 1989; Sappino et al, 1990).
The leukocytes that accumulated during the inflammatory phase
and expressed PTHrP were consistent with macrophages. Leuko-
cytes have previously been shown to produce PTHrP (Philbrick
et al, 1996). For example, hypercalcemia of malignancy due to
PTHrP overproduction has been reported with all types of leukemia
of lymphocyte and of monocyte origin (Rosol and Capen, 1992;
Philbrick et al, 1996). In addition, PTHrP has been detected in
macrophages in sarcoidosis (Zeimer et al, 1998). Factors regulating
PTHrP expression by macrophages and the function of PTHrP
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Figure 8. PTHrP expression by
infiltrating macrophages. Mononuclear
inflammatory cells infiltrating early wounds
were weak to moderately stained by
immunohistochemistry (a) and in situ
hybridization (b). These cells (arrows) were
determined to be macrophages based on
morphology and expression of lysozyme (c).
Scale bar: 100 µm.
Figure 9. PTHrP secretion by THP-1 cells detected via radio-
immunoassay. PTHrP could not be detected in the 24 h conditioned
medium of unactivated cells. Following activation with IL-1α or PMA,
THP-1 cells secreted increased levels of PTHrP into conditioned medium.
Data are expressed as mean 6 SEM for triplicate samples.
produced by leukocytes are currently unknown. Tumor necrosis
factor-α, IL-4, and interferon-α and γ, as well as inflammatory
cytokines abundant in wounds, all stimulate PTHrP production in
the whole spleen (Funk et al, 1993, 1994). Our studies using THP-
1 cells confirmed that macrophages do produce low levels of
PTHrP and demonstrated that activation was associated with
increased levels of PTHrP expression and secretion. The pattern
of expression suggested that PTHrP acts as an autocrine factor
influencing the activity or growth of macrophages. Alternatively,
PTHrP produced by macrophages may act on other cell types,
such as neighboring fibroblasts or keratinocytes to regulate the
process of wound healing.
Although the pattern of PTHrP expression in wounds is con-
sistent with an active role of PTHrP in the process of wound
healing, we did not demonstrate significant changes in the healing
rate or the morphology of the wounds following topical application
of PTHrP(1–36) or PTH(7–34). These two peptides have previously
been shown to be active in the skin following systemic injection
(Holick et al, 1994; Schilli et al, 1997). Subtle differences between
treated and nontreated wounds cannot be completely excluded, as
quantitative analyses of the wounds and of keratinocyte proliferation
and differentiation were not performed and only limited numbers
of animals were used. In addition, the absence of observed effects
may have been related to a poor epidermal or crust penetration by
Figure 10. Ethidium bromide-stained agarose gel of reverse
transcriptase-PCR amplified PTHrP mRNA. PTHrP mRNA was
detected in THP-1 cells treated with PBS (lane 1), IL-1α (lane 2), and
PMA (lane 3), as evidenced by a 321 bp amplification product. The 229 bp
GAPDH mRNA amplification product was detected in all three lanes.
Lane 4 is the negative control, consisting of RNA-free water; lane L is the
123 bp DNA ladder.
the preparations used, although two different types of vehicles were
used to minimize the likelihood of this situation. Nevertheless,
these data are similar to what occurs with other growth factors,
such as keratinocyte growth factor and transforming growth factor-
α. Although these growth factors are markedly upregulated during
wound healing, they appear dispensable for proper restoration of
the epidermis following injury because of the presence of additional
growth factors with redundant activities (Guo et al, 1996). Guo
et al (1996) suggested that the redundancy in epidermal growth
and wound healing, resulting from the complex processes and large
numbers of paracrine and autocrine regulatory factors, is a reflection
of the vitality of these functions to the organism. Like PTHrP,
most of these cytokines profoundly affect hair follicle growth, a
nonvital body function not regulated by multiple redundant growth
factors (Holick et al, 1994; Guo et al, 1996; Schilli et al, 1997).
Therefore, our data suggest that although PTHrP plays an active
role in the process of wound healing, it is not essential due to the
presence of other growth factors with compensatory activities.
Alternatively, the increased expression may simply be an epiphen-
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omenon, not associated with any particular role for PTHrP in the
healing process.
In conclusion, the spatial and temporal changes in PTHrP
expression in keratinocytes, myofibroblasts, and infiltrating macro-
phages suggest an active part for PTHrP in the process of wound
healing. Further studies are necessary to better define the role of
PTHrP in skin repair. The current availability of transgenic models
should help these further investigations, while in vitro studies should
permit identification of factors influencing PTHrP expression by
keratinocytes and myofibroblasts.
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